Research
Research Field
Keyword
Therapeutic antibody, Protein Engineering, Immune profiling with machine learning algorithm
Publication
- Jo DH, Kim JH, Yang W, Kim H, Chang S, Kim D, Chang M, Lee K, Chung J, Kim JH.
- Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal
- neovascularization. Oncotarget. 2017; 8(28):45506-45516. PubMed [journal] PMID:
- , PMCID: PMC5542204
- Heo K, Min SW, Sung HJ, Kim HG, Kim HJ, Kim YH, Choi BK, Han S, Chung S, Lee ES,
- Chung J, Kim IH. An aptamer-antibody complex (oligobody) as a novel delivery
- platform for targeted cancer therapies. Journal of controlled release : official
- journal of the Controlled Release Society. 2016; 229:1-9. PubMed [journal] PMID:
- Kim S, Kim H, Jo DH, Kim JH, Kim SR, Kang D, Hwang D, Chung J. Bispecific
- anti-mPDGFRβ x cotinine scFv-Cκ-scFv fusion protein and
- cotinine-duocarmycin can form antibody-drug conjugate-like complexes that exert
- cytotoxicity against mPDGFRβ expressing cells. Methods (San Diego, Calif.). 2018;
- PubMed [journal] PMID: 30292795
- Jin J, Park G, Park JB, Kim S, Kim H, Chung J. An anti-EGFR × cotinine bispecific
- antibody complexed with cotinine-conjugated duocarmycin inhibits growth of
- EGFR-positive cancer cells with KRAS mutations. Experimental & molecular
- medicine. 2018; 50(5):67. PubMed [journal] PMID: 29795377, PMCID: PMC5967348
- Lee HK, Lee Y, Kim H, Lee HE, Chang H, Nam KT, Jeong DH, Chung J. Screening of
- Pro-Asp Sequences Exposed on Bacteriophage M13 as an Ideal Anchor for Gold
- Nanocubes. ACS synthetic biology. 2017; 6(9):1635-1641. PubMed [journal] PMID: